全球医药及医疗设备综合产品市场规模、份额、趋势及成长分析报告（2026-2034）

预计医药和医疗设备综合市场将从 2025 年的 1,760.2 亿美元成长到 2034 年的 3,527.5 亿美元，2026 年至 2034 年的复合年增长率为 8.03%。

由于市场对能够提高疗效和患者便利性的综合医疗解决方案的需求不断增长，全球医药医疗设备一体化（PHEV）市场正在快速扩张。 PHEV 透过将药物与医疗设备结合，能够更有效地提供治疗。例如，预填充式注射器、吸入器、胰岛素输注装置以及用于各种医疗治疗的药物释放型支架等。

慢性病盛行率上升、先进药物输送系统的广泛应用以及医疗设备技术的进步是推动市场成长的主要因素。製药公司正在加速研发复合产品，旨在提高药物输送的精准度和患者依从性。此外，医疗保健投资的增加以及监管机构对创新疗法的支持也促进了市场扩张。

展望未来，随着医疗机构采用更个人化和高效的治疗方法，药物-医疗设备组合市场预计将持续成长。生物技术、数位健康技术和智慧药物传输系统的进步将进一步提升产品功能。随着医疗产业不断致力于改善治疗效果和提升患者便利性，该市场有望保持持续成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球医药及医疗设备综合产品市场：依产品类别划分

• 市场分析、洞察与预测
• 药物释放型支架
• 点滴帮浦
• 动态疗法
• 创伤护理复合产品
• 预填充式注射器
• 药物释放型球囊
• 喷雾器
• 吸入器
• 经皮吸收系统
• 整形外科复合产品
• 抗菌导管

第五章 全球医药医疗设备综合市场：依应用领域划分

• 市场分析、洞察与预测
• 心血管疾病
• 糖尿病
• 呼吸系统疾病
• 癌症治疗
• 抗菌应用
• 其他用途

第六章 全球医药及医疗设备组合产品市场：依最终用途划分

• 市场分析、洞察与预测
• 医院和诊所
• 门诊手术中心
• 居家医疗环境
• 其他最终用户

第七章 全球医药及医疗设备综合产品市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott Laboratories
  • AbbVie Inc
  • Alcon Inc
  • Bausch Health Companies Inc
  • Baxter International Inc
  • Bayer AG
  • Becton
  • Dickinson And Company
  • Boston Scientific Corporation
  • Glaxo SmithKline Plc
  • Johnson & Johnson
  • Kaleo Inc
  • Medtronic Plc
  • Novartis AG
  • Sinomed

The Drug Device Combination Products Market size is expected to reach USD 352.75 Billion in 2034 from USD 176.02 Billion (2025) growing at a CAGR of 8.03% during 2026-2034.

The Global Drug Device Combination Products Market is expanding rapidly due to the increasing demand for integrated healthcare solutions that improve treatment effectiveness and patient convenience. Drug device combination products combine pharmaceutical drugs with medical devices to deliver therapies more efficiently. Examples include prefilled syringes, inhalers, insulin delivery devices, and drug-eluting stents used in various medical treatments.

Market growth is driven by rising chronic diseases, increasing adoption of advanced drug delivery systems, and technological advancements in medical devices. Pharmaceutical companies are increasingly developing combination products to enhance drug delivery accuracy and improve patient compliance. In addition, growing healthcare investments and regulatory support for innovative treatment solutions are contributing to the expansion of the market.

Looking ahead, the drug device combination products market is expected to grow as healthcare providers adopt more personalized and efficient treatment methods. Advances in biotechnology, digital health technologies, and smart drug delivery systems will further enhance product capabilities. As the healthcare industry continues to focus on improving treatment outcomes and patient convenience, the market is likely to witness sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Drug-Eluting Stents
• Infusion Pumps
• Photodynamic Therapy
• Wound Care Combination Product
• Prefilled Syringes
• Drug-Eluting Balloons
• Nebulizers
• Inhalers
• Transdermal Delivery Systems
• Orthopedic Combination Products
• Antimicrobial Catheters

By Application

• Cardiovascular Disorders
• Diabetes
• Respiratory Problems
• Cancer Treatment
• Antimicrobial Application
• Other Applications

By End-Use

• Hospitals And Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Other End-Users

COMPANIES PROFILED

• Abbott Laboratories, AbbVie Inc, Alcon Inc, Bausch Health Companies Inc, Baxter International Inc, Bayer AG, Becton, Dickinson and Company, Boston Scientific Corporation, Glaxo SmithKline plc, Johnson Johnson, Kaleo Inc, Medtronic plc, Novartis AG, Sinomed
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Drug-Eluting Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Infusion Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Photodynamic Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Wound Care Combination Product Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Prefilled Syringes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Drug-Eluting Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Nebulizers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Inhalers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Transdermal Delivery Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.11. Orthopedic Combination Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.12. Antimicrobial Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Cardiovascular Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Respiratory Problems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Cancer Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Antimicrobial Application Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DRUG DEVICE COMBINATION PRODUCTS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories
  • 9.2.2 AbbVie Inc
  • 9.2.3 Alcon Inc
  • 9.2.4 Bausch Health Companies Inc
  • 9.2.5 Baxter International Inc
  • 9.2.6 Bayer AG
  • 9.2.7 Becton
  • 9.2.8 Dickinson And Company
  • 9.2.9 Boston Scientific Corporation
  • 9.2.10 Glaxo SmithKline Plc
  • 9.2.11 Johnson & Johnson
  • 9.2.12 Kaleo Inc
  • 9.2.13 Medtronic Plc
  • 9.2.14 Novartis AG
  • 9.2.15 Sinomed